Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ludwig

Showing results (311-320 of 912) with videos related to

Pageof 92
Sort By:
Acta Dermato-Venereologica|April 7, 2025
Distinct Impact of Phosphodiesterade-4 (PDE4) Inhibition in Two Pre-clinical Psoriasis ModelsSören Dräger, Thorge Mester, Hermann Tenor, et al.
The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine|September 1, 1971
Cholangiographic findings in cholangiolitic hepatitis. Syndrome of primary biliary cirrhosisD A Legge, H C Carlson, E R Dickson, et al.
Digestive Diseases and Sciences|July 1, 1986
Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitisR P Kenny, A J Czaja, J Ludwig, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 21, 2025
Cardiovascular and thromboembolic risks of JAK inhibitors in atopic dermatitis: A global cohort studyKhalaf Kridin, Samer Kridin, Eliza Mayer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 26, 2025
The real-world, long-term risk of infections associated with dupilumab in atopic dermatitis: A global cohort studyKhalaf Kridin, Mariam Abdelghaffar, Katja Bieber, et al.
American Journal of Clinical Dermatology|October 7, 2020
More Severe Erosive Phenotype Despite Lower Circulating Autoantibody Levels in Dipeptidyl Peptidase-4 Inhibitor (DPP4i)-Associated Bullous Pemphigoid: A Retrospective Cohort StudySascha Ständer, Enno Schmidt, Detlef Zillikens, et al.
Journal of the American Academy of Dermatology|August 10, 2023
Risk of comorbid autoimmune diseases in patients with immunobullous disorders: A global large-scale cohort studyMichael Kasperkiewicz, Artem Vorobyev, Katja Bieber, et al.
Dermatology (Basel, Switzerland)|February 28, 2021
A History of Asthma Increases the Risk of Bullous Pemphigoid: Insights from a Large Population-Based StudyKhalaf Kridin, Ralf J Ludwig, Dana Tzur Bitan, et al.
Seminars in Liver Disease|August 1, 1985
Diagnosis and treatment of primary sclerosing cholangitisR H Wiesner, J Ludwig, N F LaRusso, et al.
Gastroenterology|June 1, 1992
Papillary bile duct dysplasia in primary sclerosing cholangitisJ Ludwig, H E Wahlstrom, K P Batts, et al.
Pageof 92

Showing results (311-320 of 912) with videos related to

Sort By:
Pageof 92
Acta Dermato-Venereologica|April 7, 2025
Distinct Impact of Phosphodiesterade-4 (PDE4) Inhibition in Two Pre-clinical Psoriasis ModelsSören Dräger, Thorge Mester, Hermann Tenor, et al.
The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine|September 1, 1971
Cholangiographic findings in cholangiolitic hepatitis. Syndrome of primary biliary cirrhosisD A Legge, H C Carlson, E R Dickson, et al.
Digestive Diseases and Sciences|July 1, 1986
Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitisR P Kenny, A J Czaja, J Ludwig, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 21, 2025
Cardiovascular and thromboembolic risks of JAK inhibitors in atopic dermatitis: A global cohort studyKhalaf Kridin, Samer Kridin, Eliza Mayer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 26, 2025
The real-world, long-term risk of infections associated with dupilumab in atopic dermatitis: A global cohort studyKhalaf Kridin, Mariam Abdelghaffar, Katja Bieber, et al.
American Journal of Clinical Dermatology|October 7, 2020
More Severe Erosive Phenotype Despite Lower Circulating Autoantibody Levels in Dipeptidyl Peptidase-4 Inhibitor (DPP4i)-Associated Bullous Pemphigoid: A Retrospective Cohort StudySascha Ständer, Enno Schmidt, Detlef Zillikens, et al.
Journal of the American Academy of Dermatology|August 10, 2023
Risk of comorbid autoimmune diseases in patients with immunobullous disorders: A global large-scale cohort studyMichael Kasperkiewicz, Artem Vorobyev, Katja Bieber, et al.
Dermatology (Basel, Switzerland)|February 28, 2021
A History of Asthma Increases the Risk of Bullous Pemphigoid: Insights from a Large Population-Based StudyKhalaf Kridin, Ralf J Ludwig, Dana Tzur Bitan, et al.
Seminars in Liver Disease|August 1, 1985
Diagnosis and treatment of primary sclerosing cholangitisR H Wiesner, J Ludwig, N F LaRusso, et al.
Gastroenterology|June 1, 1992
Papillary bile duct dysplasia in primary sclerosing cholangitisJ Ludwig, H E Wahlstrom, K P Batts, et al.
Pageof 92